NCT04262466 2026-03-06
Safety and Efficacy of IMC-F106C as a Single Agent and in Combination With Checkpoint Inhibitors
Immunocore Ltd
Phase 1/2 Active not recruiting
Clinical Trials
4 trialsNCT02153229 2025-12-26
MPM-PDT
Abramson Cancer Center at Penn Medicine
Phase 2 Active not recruiting
NCT04185883 2025-10-22
Sotorasib Activity in Subjects With Advanced Solid Tumors With KRAS p.G12C Mutation (CodeBreak 101)
Amgen
Phase 1 Active not recruiting
NCT03710876 2025-05-20
INFINITE
Ferring Ventures Limited
Phase 3 Active not recruiting